Berkshire Asset Management LLC Guardant Health, Inc. Transaction History

Berkshire Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $143,293 - $384,584	-4,972 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $68,515 - $142,695	-1,420 Reduced 22.22%	4,972 $329,000
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $73,363 - $99,595	-827 Reduced 11.46%	6,392 $639,000
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $34,964 - $46,788	354 Added 5.16%	7,219 $902,000
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $28,759 - $43,408	262 Added 3.97%	6,865 $853,000
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $388,544 - $528,359	3,887 Added 143.11%	6,603 $851,000
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $10,521 - $14,645	131 Added 5.07%	2,716 $304,000
Q2 2020 Aug 12, 2020	SELL	$60.49 - $97.5 $198,407 - $319,800	-3,280 Reduced 55.92%	2,585 $210,000
Q1 2020 May 13, 2020	BUY	$59.04 - $88.81 $346,269 - $520,870	5,865 New	5,865 $408,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.98B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Berkshire Asset Management LLC with notifications on news.